Contents
  • Understanding Bone Density Tests
  • When Should You Get Tested?
  • What Do the Results Mean?

The Vital Role of Bone Density Tests for Your Health

The Vital Role of Bone Density Tests for Your Health

Why It Matters

Bone density tests are essential in detecting osteoporosis, especially for those on glucocorticoids. Learn why these tests are crucial for maintaining bone health.
Contents
  • Understanding Bone Density Tests
  • When Should You Get Tested?
  • What Do the Results Mean?

Understanding Bone Density Tests

Bone density tests, like dual-energy x-ray absorptiometry (DXA), are used to measure bone strength, particularly in the spine and hip. These tests help doctors assess the risk of fractures and plan appropriate treatments to prevent bone loss.

When Should You Get Tested?

Anyone on glucocorticoid therapy for three months or more should consider a bone density test. The test can reveal early signs of osteoporosis, enabling timely interventions to protect your bones from further damage.
A bone density test measures the strength and density of bones to help diagnose osteoporosis and assess fracture risk, particularly in the spine and hip.

What Do the Results Mean?

The results of a bone density test are usually given as a T-score. A score of -2.5 or lower indicates osteoporosis. Knowing your score helps you and your doctor make informed decisions about your bone health and necessary treatments.

FAQs

What is a bone density test?

It's a scan that measures bone strength and checks for osteoporosis.

Who needs a bone density test?

Anyone on long-term glucocorticoid therapy should get tested.

How are test results interpreted?

Results are given as a T-score, with -2.5 or lower indicating osteoporosis.

The Bottom Line

Bone density tests are a vital tool for proactively managing your bone health.
Think you might need a bone density test? Ask Doctronic about scheduling one today!
Additional References
  1. Cohen S, Levy RM, Keller M, et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 1999; 42:2309.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.